发明名称 |
FORMULATION FOR ORAL ADMINISTRATION OF PROTEINS |
摘要 |
PROBLEM TO BE SOLVED: To provide pharmaceutical formulations of orally administered proteins which can be stabilized from oxidative degradation and inactivation in the stomach and gastrointestinal (GI) tract.SOLUTION: The invention provides a solid pharmaceutical formulation of a barley endoprotease B-2 suitable for oral administration with a unit dosage form, or a recombinant form or modified form of barley endoprotease B-2. The solid pharmaceutical formulation is a capsule form; a powder, sprinkle, or particle in the capsule or a sachet; or a tablet form, comprising about 2 to 50 mg of sodium metabisulfite and 50-2000 mg of the EPB2. |
申请公布号 |
JP2015110610(A) |
申请公布日期 |
2015.06.18 |
申请号 |
JP20150005678 |
申请日期 |
2015.01.15 |
申请人 |
ALVINE PHARMACEUTICALS INC |
发明人 |
MATTHEW JOHN SIEGEL;BRET BERNER |
分类号 |
A61K38/46;A61K9/14;A61K9/20;A61K9/48;A61K47/02;A61K47/12;A61K47/18;A61P1/00;A61P1/04;A61P17/00 |
主分类号 |
A61K38/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|